According to a recent study, upadacitinib is efficacious and demonstrated a favorable benefit-risk profile for long-term treatment of atopic dermatitis (AD) in adolescent patients.
top of page
it's where dermatology lives
bottom of page
According to a recent study, upadacitinib is efficacious and demonstrated a favorable benefit-risk profile for long-term treatment of atopic dermatitis (AD) in adolescent patients.
Commenti